市場調查報告書
商品編碼
1593526
藥品合約包裝市場規模、佔有率和成長分析(按類型、包裝材料和地區):產業預測(2024-2031)Pharmaceutical Contract Packaging Market Size, Share, Growth Analysis, By Type (Primary Packaging, Secondary Packaging), By Material (Plastics & Polymers, Paper & Paperboard), By Region - Industry Forecast 2024-2031 |
2022年全球藥品合約包裝市場規模為56.5億美元,從2023年的61.1億美元擴大到2031年的109.1億美元,在預測期內(2024-2031年)預計複合年成長率為7.51。百分比)。
在新興市場對合約包裝公司的需求不斷成長以及製藥行業的外包趨勢的推動下,高品質化學包裝市場預計將顯著成長。製藥公司擴大將合約包裝服務作為降低製造成本的策略,特別是考慮到許多小型製藥公司面臨的挑戰,例如內部包裝材料、專業知識和財務資源的限制。為了有效克服這些限制,這些小型製藥公司正在與合約包裝組織 (CPO) 和契約製造組織 (CMO) 建立有益的夥伴關係。因為外包包裝解決方案不僅提供了獲得先進技術的機會,還可以讓企業專注於其核心業務領域,簡化包裝流程,並提高服務效率。因此,CPO 和合約開發與製造組織 (CDMO) 日益成為尋求最佳化業務並確保在競爭環境中提供高品質包裝解決方案的製藥公司的首選。這種動態演進凸顯了外包在提高藥廠在市場上的能力和競爭力方面所發揮的重要作用。
Global Pharmaceutical Contract Packaging Market size was valued at USD 5.65 billion in 2022 and is poised to grow from USD 6.11 billion in 2023 to USD 10.91 billion by 2031, growing at a CAGR of 7.51% during the forecast period (2024-2031).
The market for high-quality chemical packaging is poised for significant growth, driven by rising demand from contract packers in emerging markets and a trend towards outsourcing within the pharmaceutical sector. Pharmaceutical companies are increasingly turning to contract packaging services as a strategy to lower manufacturing costs, particularly in the face of challenges such as limited in-house packaging materials, expertise, and financial resources that many small players encounter. These small pharmaceutical firms are forming beneficial partnerships with contract packaging organizations (CPOs) and contract manufacturing organizations (CMOs) to effectively navigate these constraints. The global expansion of the pharmaceutical industry further supports this trend, as outsourcing packaging solutions not only provides access to advanced technologies but also allows companies to focus on core business areas, streamline packaging processes, and enhance service efficiency. Consequently, CPOs and contract development and manufacturing organizations (CDMOs) are increasingly becoming the preferred choice for pharmaceutical companies seeking to optimize their operations and ensure high-quality packaging solutions amid a competitive landscape. This evolving dynamic underscores the vital role that outsourcing plays in elevating the capabilities and competitiveness of pharmaceutical manufacturers in the marketplace.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Contract Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Contract Packaging Market Segmental Analysis
Global Pharmaceutical Contract Packaging Market is segmented by Type, Material, and region. Based on Type , the market is segmented into Primary Packaging (Bottles, Vials, Ampoules, Blister Packs, Others), Secondary Packaging, Tertiary Packaging. Based on Material, the market is segmented into Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Contract Packaging Market
The Global Pharmaceutical Contract Packaging market is significantly driven by the increasing trend of outsourcing among pharmaceutical companies. As these organizations confront complex packaging requirements, stringent regulatory standards, and cost-performance pressures, they increasingly turn to specialized contract packaging providers. This strategic shift allows pharmaceutical firms to focus on core activities such as drug development and marketing, while benefiting from the expertise of contract packaging companies that can deliver innovative, compliant, and efficient packaging solutions. Consequently, this outsourcing trend not only enhances operational efficiency but also fosters better resource allocation, making it a pivotal factor in the growth of the contract packaging market.
Restraints in the Global Pharmaceutical Contract Packaging Market
The Global Pharmaceutical Contract Packaging market faces significant restraints due to the complexities of regulatory compliance that vary across different countries. Each region imposes distinct packaging and labeling guidelines, as well as stringent requirements for indestructible seals and durability warranties. The financial burden associated with meeting these diverse standards can be substantial, particularly for small- and medium-sized contract packaging firms that may lack the necessary resources. Moreover, the potential repercussions of non-compliance, such as product recalls or legal liabilities, further deter these companies from actively participating in the market, ultimately hindering overall market growth and innovation.
Market Trends of the Global Pharmaceutical Contract Packaging Market
The Global Pharmaceutical Contract Packaging market is witnessing a significant trend towards adopting sustainable packaging solutions, driven by heightened regulatory scrutiny and consumer demand for environmentally-friendly practices. Companies are increasingly prioritizing eco-conscious alternatives by integrating biodegradable plastics, recyclable materials, and minimizing bulky packaging. This shift is forcing packaging contract providers to invest in research and development initiatives aimed at creating innovative packaging products that align with stringent regulatory standards while also addressing sustainability goals. As governments enforce stricter environmental regulations and consumers champion greener initiatives, the emphasis on sustainable packaging is poised to grow, reshaping strategies within the pharmaceutical industry.